Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1394studies shown
Showing 1-25 of 1,394
CompletedNCT05956340

A Study of Spoken Language in Mania

This study is completed. It focuses on bipolarity and currently lists study information in the United States.

BipolarityOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Mayo Clinic
Condition
Bipolarity
RecruitingNCT06929273

A Study to Assess the Long-term Safety of KarXT for the Treatment of manic episodes in Bipolarity type I (BALSAM-3)

This study is recruiting. It focuses on bipolarity and currently lists participation information in Argentina, Australia, Bulgaria, China, Croatia, Denmark, France, Hungary, India, Israel, Italy, Japan, New Zealand, Poland, Romania, Slovakia, Spain, Sweden, Ukraine, and the United States.

BipolarityOtherFrom 18 Years to 65 Years
Countries
Argentina, Australia, Bulgaria, China, Croatia, Denmark, France, Hungary, India, Israel, Italy, Japan, New Zealand, Poland, Romania, Slovakia, Spain, Sweden, Ukraine, United States
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
RecruitingNCT07140913

A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolarity type I Taking Lithium, Valproate, or Lamotrigine

This study is recruiting. It focuses on bipolarity and currently lists participation information in Argentina, Bulgaria, China, Denmark, France, India, Israel, Italy, Japan, Poland, Romania, Ukraine, and the United States.

BipolarityOtherFrom 18 Years to 65 Years
Countries
Argentina, Bulgaria, China, Denmark, France, India, Israel, Italy, Japan, Poland, Romania, Ukraine, United States
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
RecruitingNCT06951698

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of manic episodes in Bipolarity type I

This study is recruiting. It focuses on bipolarity and currently lists participation information in Argentina, Australia, Bulgaria, Hungary, Japan, New Zealand, Poland, and the United States.

BipolarityOtherFrom 18 Years to 65 Years
Countries
Argentina, Australia, Bulgaria, Hungary, Japan, New Zealand, Poland, United States
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
RecruitingNCT06951711

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of manic episodes in Bipolarity type I (BALSAM-2)

This study is recruiting. It focuses on bipolarity and currently lists participation information in Croatia, India, Israel, Italy, Romania, Slovakia, Spain, Sweden, Ukraine, and the United States.

BipolarityOtherFrom 18 Years to 65 Years
Countries
Croatia, India, Israel, Italy, Romania, Slovakia, Spain, Sweden, Ukraine, United States
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
RecruitingNCT06656416

ALTO-100 in Bipolarity With Depression (BD-D)

This study is recruiting. It focuses on depression and currently lists participation information in the United States.

DepressionOtherFrom 18 Years to 70 Years
Countries
United States
Sponsor
Alto Neuroscience
Condition
Depression
Bipolarity | Clinical Trials | HopeStage Research